FindTrial
Sign In

Circumcision plus antibiotics, anti-inflammation and alpha-blocker therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome: A prospective, randomized, multicenter trial

Circumcision plus antibiotics, anti-inflammation and alpha-blocker therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome: A prospective, randomized, multicenter trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004567
Enrollment
Unknown
Registered
2014-04-23
Start date
2013-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic prostatitis/chronic pelvic pain syndrome

Interventions

circumcision group:circumcision+ciprofloxacin+ibuprofen+tamsulosin
control group:ciprofloxacin+ibuprofen+tamsulosin

Sponsors

Shanghai First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18–50 years old; 2. Redundant prepuce,uncircumcised men with discomfort in the pelvic region for at least 3 months and may accompany varying degrees of urinary symptoms and sexual dysfunction; 3. Negative bacterial culture in EPS, preprostatic and postprostatic massage urine, and with or without leukocytosis in EPS.

Exclusion criteria

Exclusion criteria: 1. Urinary tract infection; 2. A history of prostate cancer; 3. Inguinal hernia; 4. Inflammatory bowel disease; 5. Urethral stricture; 6. Prostate or bladder surgery patients; 7. Circumcised patients.

Design outcomes

Primary

MeasureTime frame
NIH-CPSI score;—

Countries

China

Contacts

Public ContactShujie Xia

Department of Urology, Shanghai First People's Hospital, Institute of Urology

xsjurologist@gmail.com+86 18918079921

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026